ClinicalTrials.gg
CompletedNCT03755011Updated Apr 1, 2019

White Noise to Improve Sleep in the Medical Intensive Care Unit (MICU): a Pilot and Feasibility Study

An interventional study of white noise and usual care in Sleep Deprivation, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-01.

Sponsored by Yale University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A feasibility study to evaluate the use of white noise to improve sleeping conditions in an ICU setting.

Read the detailed description

The ICU is full of alarms and critically ill patients, so it is no surprise that sleep is very much fragmented and poor in this setting, as documented in numerous studies. White noise is a simple intervention that has been shown to improve sleep, including in the ICU setting. The aim is to conduct a pilot trial evaluating the feasibility of providing white noise to patients in the ICU at night to help improve sleep. The plan to measure feasibility metrics including patient acceptance, patient tolerance, and intervention fidelity; also to seek feedback from patients, nurses, and providers. Secondly is to evaluate the benefits of providing white noise at night in the ICU on sleep as measured by actigraphy and Richards-Campbell Sleep Questionnaires and total room sound.

02

Conditions studied

  • Sleep Deprivation

Browse trials for

03

In context

Sleep Deprivation

308 studies on the registry are indexed under Sleep Deprivation; 62 are open to participants now.

This study's enrollment of 7 is below the median of 44 across 253 interventional studies indexed under Sleep Deprivation.

Browse Sleep Deprivation studies →

Lead sponsor

Yale University is the lead sponsor of 1,763 studies on the registry; 292 are open to participants now.

Of its 217 completed or terminated interventional studies of FDA-regulated products, 128 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults >18yo admitted to MICU with expected stay of at least two nights after enrollment

Exclusion criteria

Exclusion Criteria:

  • Excluding intubated patients (so communication can be better) and patients on high-flow nasal cannula (which is already high background noise).
  • Patients who are on therapeutic hypothermia or are on comfort measures only will also be excluded
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
7 participants (actual)

Study arms

  • Experimental
    patients exposed to white noise

    Six patients in the interventional arm will have white noise (through in-room workstations- on-wheels and publicly-available white noise websites) playing overnight at a standardized volume to be determined; pausing will be at nurse, provider, and patient discretion during routine care and conversations with the patients.

    Device: white noise

  • Placebo comparator
    usual care

    Six patients exposed to normal ICU activity noise.

    Behavioral: usual care

Interventions

  • Devicewhite noise

    Patients in the interventional arm will have white noise (through in-room workstations- on-wheels and publicly-available white noise websites) playing overnight at a standardized volume to be determined.

  • Behavioralusual care

    normal ICU activity noise

06

What researchers measure

Primary outcomes

  1. Intervention fidelity: percent of intervention time during which white noise is actually delivered

    percent of intervention time during which white noise is actually delivered

    Time frame: 48 hours

Secondary outcomes

  1. Sound Levels

    Room dBA and dBC-weighted sound levels will be measured in the rooms as well by HD600 sound meters (Extech Instruments) every 10 seconds throughout the night shift; sound meters will be placed on the wall behind and 10" above the head of the bed (set when head of bed is at 30 degrees).

    Time frame: 48 hours

  2. Sleep Questionnaire: Sleep Questionnaire. Patients will be surveyed after Study Night 1 and Study Night 2 with Richards- Campbell Sleep Questionnaires.

    Sleep Questionnaire. Patients will be surveyed after Study Night 1 and Study Night 2 with Richards- Campbell Sleep Questionnaires. Scores will be graded on a scale of 0-100, as measured in mm on the visual scale; 100 representing a more positive sleep experience.

    Time frame: 48 hours

  3. Actigraphic rest-activity :Patients will wear Actiwatch Spectrum devices to measure rest-activity patterns. Sleep will be identified using Actiwatch Software as provided by the manufacture.

    Patients will wear Actiwatch Spectrum devices to measure rest-activity patterns. Sleep will be identified using Actiwatch Software as provided by the manufacture.

    Time frame: 48 hours

  4. Patient tolerance: percent of days that patients agree to continue white noise

    percent of days that patients agree to continue white noise

    Time frame: 48 hours

  5. Patient acceptance: percent of patients or surrogates who agree to receive white noise at night

    percent of patients or surrogates who agree to receive white noise at night

    Time frame: 48 hours

07

Study locations

1 site
  • Yale New Haven Hospital
    New Haven, Connecticut 06510, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2018 to primary completion in Mar 2019, 3 months.

Of 142 non-industry interventional studies with no phase under Sleep Deprivation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's 3 months is below that.

Counting every sponsor, half of 151 studies reached it within 17 months; a quarter within 8 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2018
First posted
Nov 27, 2018
StartActual
Nov 27, 2018
Primary completionActual
Mar 15, 2019
CompletionActual
Mar 15, 2019
Last update
Apr 1, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03755011
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Nov 27, 2018
Start date
Nov 27, 2018
Primary completion
Mar 15, 2019
Completion
Mar 15, 2019
Last update
Apr 1, 2019

Study contacts

Catherine Gao, MD
principal investigator · Yale University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion